Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
Inflammation and Immune Response: Providing insight into chronic inflammation and gut-related immune issues
doi: 10.1016/j.lfs.2011.01.015
Reported ranges from research/community examples, not recommendations
How does the mechanism of action of 5-Amino-1MQ work
Most people find these effects diminish over time as the body adapts, but the initial adjustment period can be genuinely unpleasant
